| Contributors: |
Muller, P. C.; Berchtold, C.; Kuemmerli, C.; Breuer, E.; Li, Z.; Vallorani, A.; Hansen, C.; Guidetti, C.; Eden, J.; Campbell, B. A.; Wu, P.; Cecchetto, S. N.; Gudmundsdottir, H.; Kendrick, M.; Starlinger, P. P.; Pecorelli, N.; Guarneri, G.; Farooqui, W.; Tschuor, C.; Burgdorf, S. K.; Muhlhausser, J.; Gass, J. -M.; Goh, B. K. P.; Koh, Y. -X.; Rebelo, A.; Kleeff, J.; Seip, T.; Santibanes, M.; Todeschini, L.; Marchegiani, G.; Belfil, N.; Lesurtel, M.; Machado, M.; Boggi, U.; Kauffmann, E.; Cappelle, M.; Koerkamp, B. G.; Di Benedetto, F.; Roberts, K.; Nevler, A.; Lavu, H.; Dutkowski, P.; Nickel, F.; Hackert, T.; He, J.; Falconi, M.; Truty, M.; Billeter, A. T.; Muller, B. P.; Halle-Smith, J.; Valle, V.; Giulianotti, P.; Giannone, F.; Pessaux, P.; Sanchez-Velazquez, P.; Thapa, P. B.; Maharjan, D.; Torres, O.; Kuzman, M.; Pandanaboyana, S. |
| Description: |
Importance: Total pancreatectomy (TP) is indicated for advanced pancreatic cancer or multifocal tumors. Furthermore, TP may be performed to avoid the risk of pancreatic fistula in selected patients to improve the perioperative risk profile. Objective: To define reference values for TP based on a low-risk cohort treated at expert centers. Design, Setting, and Participants: This multicenter study analyzed outcomes from patients undergoing primary TP for malignant or benign lesions from 25 international expert centers from January 2017 to November 2023. Low-risk patients undergoing TP (LR-TP) were without vascular resections or significant comorbidities. Exposures: TP. Main Outcomes and Measures: Twenty reference values were derived from the 75th or the 25th percentile of the median values of all centers. Outcomes of LR-TP were compared with a cohort of TP with vascular resection, TP due to high-risk pancreatic anastomosis, and the benchmark values for low-risk pancreatoduodenectomy. Results: Of 994 patients, 333 (33.5%; median [IQR] age, 66 [58-72] years; 171 male [51.4%]) qualified as the LR-TP cohort. Reference values included blood loss (≤1000 mL), major complications (≤37%), 3-month postoperative mortality ( |